期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性冠脉综合征生物标志物研究的进展 被引量：8

下载PDF
导出
摘要 急性冠脉综合征（Acute coronary syndromes．ACS）是指动脉粥样硬化斑块脱落、血小板聚积、血栓形成导致冠状动脉狭窄、阻塞。引起心肌缺血以及梗死的病理现象。临床上，它涵盖了一组连续进展的病症，包括不稳定心绞痛（UA）、
作者 王继贵
机构地区 中南大学湘雅二医院检验科
出处 《实验与检验医学》 CAS 2009年第5期514-516,共3页 Experimental and Laboratory Medicine
关键词 急性冠脉综合征 生物标志物 动脉粥样硬化斑块 冠状动脉狭窄 不稳定心绞痛 血小板聚积 血栓形成 病理现象
分类号 R541.4 [医药卫生—心血管疾病] R135.12 [医药卫生—内科学]
  • 相关文献

参考文献28

  • 1Vittorini S, Clerico A. Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice [J]. Clin Chem Lab Med, 2008:748-763. 被引量：1
  • 2Ladue JS, Wroblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute myocardial infarction[J]. Science 1954, 120:497-499. 被引量：1
  • 3Wu AH, Apple FS, Gibler WB. et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice. Recommendation for the use of cardiac markers in coronary artery diseases[J]. Clin Chem, 1999,45:1104-1121. 被引量：1
  • 4Apple FS, Jesse RL, Newby LK, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes[J]. Clin Chem, 2007,53:547-551. 被引量：1
  • 5Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilizations of Biochemical Markers in Acute Coronary Syndromes[J]. Clin Chem, 2007,53:552-574. 被引量：1
  • 6Packard RRS, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction[J]. Clin Chem 2008, 54:24-38. 被引量：1
  • 7Labarrere CA, Zaloga GP. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis[J]. Am J Med, 2004, 117:499-507. 被引量：1
  • 8Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques [J]. Am J Pathol, 2001, 158:1039-1051. 被引量：1
  • 9Pearson TA, Mensah GA, Hong Y, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to clinical and public health practicc: overview[J]. Circulation, 2004, 110:543-544. 被引量：1
  • 10Ridker PM. Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein(hs-CRP) in clinical practice[J]. Am Heart Hosp J, 2004,2(Supl 1):4-9. 被引量：1

二级参考文献11

  • 1[1]Wu AH,Apple FS,Giblet WB,et al.National Academy of Clinial Biochemistry Standards of Laboratory Practice:recommendations for the use of cardiac markers in coronary artery diseases[J].Clin Chem,1999,45:1104～1121. 被引量：1
  • 2[2]Apple FS,Jesse RL,Newby LK,et al.Na.tional Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines:analytical issues for biochemical markers of acute coronary syndromes[J].Clin Chem,2007,53:547～551. 被引量：1
  • 3[3]Morrow DA,Cannon CP,Jesse RL,et al.National Academy of Clinical Biochemistry Laborotory Medicine Practice Guidelines:Clinical Characteristics and Utilizations of Biochemical Markers in Acute Coronary Syndromes[J].Clin Chem,2007,53:552～574. 被引量：1
  • 4[4]Christenson RH.National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Synchromesh and Heart Failure[J].Clin Chem,2007,53:545～546. 被引量：1
  • 5[5]Panteghini M,Gerhardt W,Appple FS,et al.Toward standardization of cardiactroponin assays[J].Clin Chem Leb Med,2001,39:174～178. 被引量：1
  • 6[6]Christenson RH,Duh SH,Apple FS,et al.Toward standardization of cardiac troponin I measurement.Part Ⅱ:Assessing commutability of candidate reference materials and harmonization cardiac troponin I assays[J].Clin Chem,2006,52:1685～1692. 被引量：1
  • 7[7]Clinical and laboratory standards institute.Protocols for determinafion of limits of detection and limits of quantization:Approved guideline[S].CLSI document EPl7-A,2004. 被引量：1
  • 8[8]Clinical and laboratory standards institute.Evaluation of precision performance of quantitative measurement methods:Approved guideline[S].2nd ed CLSI document EP5-A2,2004 被引量：1
  • 9[9]Novis DA,Jones BA,Dale IC,et al.Biochemical marKers of myocardial injury test turnaround time:a college of american pathologists Q-probe study[J].Arch Path Lab Med,2004,128:158～164. 被引量：1
  • 10[10]Apple FS,Chung AY,kogut ME,et al.Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit[J].Clin Chim Acts,2006,370:191～195. 被引量：1

共引文献2

同被引文献56

引证文献8

二级引证文献14

实验与检验医学
2009年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部